Literature DB >> 21843562

A strategy to deliver genes to cystic fibrosis lungs: a battle with environment.

Basma M Ibrahim1, Seungman Park, Bumsoo Han, Yoon Yeo.   

Abstract

Cystic fibrosis (CF) sputum, a tenacious biopolymer network accumulating in the airways, critically interferes with the effectiveness of pulmonary gene delivery. To overcome this challenge, nanoparticulate ternary gene-polymer complexes were encapsulated in inhalable dry microparticles containing mannitol. When applied on a layer of artificial sputum, which comprised major components of CF sputum such as DNA and mucin, mannitol microparticles rapidly dissolved in it and enhanced transport of nanoparticles across the sputum layer. Despite the improvement of nanoparticle transport in the artificial sputum, the gene-polymer complex passing the sputum did not show gene transfection because of the significant inactivation by DNA and, to a lesser extent, mucin. Particle size measurement suggested that aggregation of the gene transfer agents was mainly responsible for the activity loss. These results indicate that the delivery of gene transfer agent across CF sputum depended not only on the ability to penetrate the sputum but also on preservation of the activity during and/or after the transport.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21843562     DOI: 10.1016/j.jconrel.2011.07.039

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  7 in total

Review 1.  The Mucus Barrier to Inhaled Gene Therapy.

Authors:  Gregg A Duncan; James Jung; Justin Hanes; Jung Soo Suk
Journal:  Mol Ther       Date:  2016-09-20       Impact factor: 11.454

2.  Preparation of methotrexate-loaded, large, highly-porous PLLA microspheres by a high-voltage electrostatic antisolvent process.

Authors:  Ai-Zheng Chen; Yue-Mei Yang; Shi-Bin Wang; Guang-Ya Wang; Yuan-Gang Liu; Qing-Qing Sun
Journal:  J Mater Sci Mater Med       Date:  2013-05-10       Impact factor: 3.896

Review 3.  Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches.

Authors:  Sylvia Natalie Kłodzińska; Petra Alexandra Priemel; Thomas Rades; Hanne Mørck Nielsen
Journal:  Int J Mol Sci       Date:  2016-10-09       Impact factor: 5.923

4.  Mechanistic insight into the interaction of gastrointestinal mucus with oral diblock copolymers synthesized via ATRP method.

Authors:  Jiao Liu; Jie Cao; Jianhua Cao; Shangcong Han; Yan Liang; Mingfeng Bai; Yong Sun
Journal:  Int J Nanomedicine       Date:  2018-05-15

5.  Radiation-enhanced delivery of plasmid DNA to tumors utilizing a novel PEI polyplex.

Authors:  Oliver K Appelbe; Bieong-Kil Kim; Nick Rymut; Jianping Wang; Stephen J Kron; Yoon Yeo
Journal:  Cancer Gene Ther       Date:  2017-12-19       Impact factor: 5.987

Review 6.  Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis.

Authors:  Cecilia Velino; Francesca Carella; Alessio Adamiano; Maurizio Sanguinetti; Alberto Vitali; Daniele Catalucci; Francesca Bugli; Michele Iafisco
Journal:  Front Bioeng Biotechnol       Date:  2019-12-17

Review 7.  Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery.

Authors:  Ji Young Yhee; Jintaek Im; Richard Seonghun Nho
Journal:  J Clin Med       Date:  2016-09-20       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.